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A B S T R A C T
Fibro-adipogenic progenitors (FAPs) are resident mesenchymal progenitors in adult skeletal muscle that support
muscle repair, but also give rise to ﬁbrous and adipose inﬁltration in response to disease and chronic injury. FAPs
are identiﬁed using cell surface markers that do not distinguish between quiescent FAPs and FAPs actively
engaged in the regenerative process. We have shown previously that FAPs are derived from cells that express the
transcription factor Osr1 during development. Here we show that adult FAPs express Osr1 at low levels and
frequency, however upon acute injury FAPs reactivate Osr1 expression in the injured tissue. Osr1+ FAPs are
enriched in proliferating and apoptotic cells demonstrating that Osr1 identiﬁes activated FAPs. In vivo genetic
lineage tracing shows that Osr1+ activated FAPs return to the resident FAP pool after regeneration as well as
contribute to adipocytes after glycerol-induced fatty degeneration. In conclusion, reporter LacZ or eGFP-CreERt2
expression from the endogenous Osr1 locus serves as marker for FACS isolation and tamoxifen-induced ma-
nipulation of activated FAPs.
1. Introduction
The remarkable regenerative potential of skeletal muscle relies on
myogenic stem cells (satellite cells), however other interstitial popula-
tions play a critical supportive role (Bentzinger et al., 2013; Uezumi
et al., 2014a; Pannerec et al., 2012). Amongst these, ﬁbro-adipogenic
progenitors (FAPs) have attracted immense attention in the past years.
FAPs are muscle-interstitial resident mesenchymal progenitor cells that
have the capacity to provide a pro-myogenic environment for muscle
regeneration (Joe et al., 2010) but also contribute directly to ﬁbrotic
degeneration and fatty inﬁltration in diseased or degenerating muscle
(Uezumi et al., 2011; Uezumi et al., 2010; Lemos et al., 2015; Kopinke
et al., 2017). As such, FAPs are important cell targets for therapeutic
approaches (Lemos et al., 2015; Mozzetta et al., 2013; Contreras et al.,
2016; Gonzalez et al., 2017). FAPs are activated upon injury to pro-
liferate (Joe et al., 2010; Uezumi et al., 2010) and are cleared by
apoptosis in the course of regeneration (Lemos et al., 2015). The
intrinsic mechanisms of activation and pro-myogenic function as well
as the mechanisms that promote ﬁbrotic or adipogenic conversion are
not well understood. Murine FAPs were characterized using diﬀerent
cell surface marker combinations. Joe et al. (Joe et al., 2010) used the
combination of linˉ;Sca1+;CD34+ or equivalently linˉ;α7-in-
tegrinˉ;Sca1+ to isolate FAPs, while Uezumi et al. (Uezumi et al., 2010;
Uezumi et al., 2014b) used linˉ;PDGFRα+ to isolate FAPs from mouse
and human muscle. Both, the Sca1+ and PDGFRα+ populations appear
to largely overlap (Uezumi et al., 2014a). In addition, FAPs show
overlap with Tcf4+ cells originally deﬁned as muscle connective tissue
ﬁbroblasts (Murphy et al., 2011; Vallecillo-García et al., 2017) as well
as with the PDGFRα+ subpopulation of PICs (PW1+ interstitial cells).
PICs are Sca1+ and CD34+ and are marked by expression of the pa-
ternally imprinted gene PW1 (Peg3), which is a general stem cell/
progenitor cell marker (Besson et al., 2011; Berg et al., 2011). PICs were
originally characterized as an interstitial multipotent population dis-
tinct from satellite cells (Mitchell et al., 2010). Later it was shown that
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PICs can be divided into PDGFRα+ adipogenic PICs that completely
overlap with FAPs as well as PDGFRαˉ myogenic PICs (Pannerec et al.,
2013). The above mentioned markers label tissue-resident quiescent
FAPs as well as FAPs activated upon injury or disease. To date, no
molecular marker has been found to identify injury-activated FAPs, and
no tool exists to speciﬁcally purify or manipulate this population, pre-
cluding analyses as well as genetic manipulation or in vivo lineage
tracing of injury-activated FAPs. The identiﬁcation of an activated FAP-
speciﬁc molecular marker promises to greatly facilitate our under-
standing of the intrinsic mechanisms of FAP activation, function, and
diﬀerentiation under normal or pathological conditions. Here we show
that FAPs become positive for the transcription factor Osr1 (Odd
skipped-related 1) in response to injury and that Osr1 expression can be
used to follow, isolate, and genetically mark activated FAPs during
pathological and normal muscle repair.
2. Results and discussion
2.1. Osr1 is expressed in a small number of adult FAPs
During development, Osr1 marks a lateral plate mesoderm-derived
population of ﬁbro-adipogenic cells that is also a source for adult Sca1+
and PDGFRα+ FAPs (Vallecillo-García et al., 2017). However, Osr1
expression declines during development and early postnatal life in
mice, and eGFP expressed from the Osr1 locus [Osr1GCE mouse line; 19]
is only detectable in situ by antibody staining during early postnatal life
but is below detectable levels in adults (Vallecillo-García et al., 2017).
To increase detection sensitivity, we inserted a β-galactosidase (β-Gal)
reporter into the Osr1 locus (Osr1LacZ, Fig. S1A), which allows for en-
zymatic signal ampliﬁcation. The expression of the Osr1LacZ allele re-
capitulated the developmental expression pattern of Osr1 (Fig. S1B).
Using the Osr1LacZ line, we observed the presence of a low number of
Osr1+ cells in the interstitium of several muscles examined (Fig. 1A).
We noted that these cells are also positive for PDGFRα (Fig. 1B). FACS-
cytospin of FAPs (linˉ;α7-integrinˉ;Sca1+) isolated from whole hin-
dlimb muscle of Osr1LacZ mice revealed that approx. 4,5% of adult FAPs
were Osr1-β-Gal+ (Fig. 1C, Fig. S2). No β-Gal Signal was detected in
linˉ;α7-integrinˉ;Sca1ˉ cells (double negative, DN cells) or linˉ;α7-in-
tegrin+;Sca1ˉ cells (mainly satellite cells, SC) (Fig. 1C). We com-
plemented this approach by isolating FAPs from PW1LacZ animals
(linˉ;PW1+;PDGFRα+); this protocol yielded a population that com-
pletely overlapped FAPs (Pannerec et al., 2013). Low abundance of
Osr1 mRNA in adult FAPs was conﬁrmed by semiquantitative PCR
(Fig. 1D). This suggests that Osr1 is expressed in a small proportion of
adult FAPs and is consistent with deep RNA sequencing data from adult
resident FAPs showing low Osr1 mRNA expression (Ollitrault et al. in
preparation).
2.2. Osr1 expression is induced to high levels upon acute injury
Freeze-pierce injury performed on Osr1LacZ tibialis anterior (TA)
muscle led to an accumulation of Osr1+ cells in the injured region 3
and 5 days post injury (dpi) (Fig. 2A). We used both Osr1GCE and
Osr1LacZ alleles to analyze which cells initiated Osr1 expression. First,
FAPs were FACS isolated from Osr1GCE mice as linˉ;α7-integrinˉ;Sca1+
[4; Fig. S3A, B] and analyzed for Osr1-eGFP expression. Using this al-
lele, we found that in uninjured muscle approx. 3,3% of FAPs expressed
Osr1-eGFP (Fig. 2B), in agreement with results obtained from the
Osr1LacZ line (Fig. 1C). The numbers of Osr1-eGFP+ FAPs increased
upon injury to 17–19% (approx. 5–6 fold increase) at 3, 5 and 7 dpi
(Fig. 2B). At 10 dpi, the fraction of Osr1-eGFP+ FAPs decreased (8,5%;
Fig. 2B). We note that the freeze-pierce injury we used results in a re-
latively small lesion leaving the larger part of the muscle uninjured. Cell
isolation from the whole TA muscle yields FAPs mainly from non-in-
jured and to a minor fraction only from injured regions. Therefore these
numbers reﬂect the relative increase in Osr1+ FAPs amongst all
(injured and uninjured region-derived) FAPs, but does not reﬂect the
absolute number of Osr1+ FAPs speciﬁcally within the regenerating
region.
Osr1-eGFP was exclusively expressed in linˉ;α7-integrinˉ;Sca1+
FAPs and not detected in linˉ;α7-integrin+;Sca1ˉ SCs or linˉ;α7-
integrinˉ;Sca1ˉ DN cells at 5 dpi (Fig. S3C). The induction of Osr1 was
conﬁrmed by detection of Osr1 protein in whole TA muscle lysates at
3dpi. We note that Osr1 protein levels are abundant in E13.5 limbs and
injured adult TA muscles whereas Osr1 protein levels were below the
level of detection in uninjured muscles (Fig. S4). Despite testing 5
commercially available antibodies (see Materials and Methods) we
were not able to detect Osr1 protein on tissue sections after injury.
Cytospin analysis of all linˉ; α7-integrinˉ; Sca1+ FAPs (i.e. GFP+
and GFPˉ) followed by immunolabeling for PDGFRα conﬁrmed that
18–20% of all PDGFRα+ FAPs (from injured and uninjured parts of the
TA muscle) were Osr1-GFP+ at 3, 5 and 7 dpi, while this ratio declined
to 10,7% at 10 dpi (Fig. 2C). In contrast, more than 85% of Osr1+ FAPs
were positive for PDGFRα at all time points analyzed (Fig. 2C, Fig.
S5A). Both the Osr1+ and the Osr1ˉ fraction of Sca1+ FAPs overlapped
partly with Tcf4 expression (Fig. 2C, Fig. S5A) indicating that there is
no correlation between Osr1 and Tcf4 expression. This was conﬁrmed
by comparing Tcf4 and PDGFRα expression at 3 and 7 dpi as early and
late stages after injury (Fig. S5B). Based on the ﬁnding that Tcf4 cells
express PDGFRα (Murphy et al., 2011) it was suggested that FAPs and
the Tcf4 pool largely overlap (Uezumi et al., 2014a). Of note, Tcf4 is
expressed in interstitial cells in uninjured as well as in injured muscle
parts (Murphy et al., 2011). We found a variable overlap of PDGFRα
and Tcf4, suggesting that (at least in an injured muscle) only a pro-
portion of Sca1+ and/or PDGFRα+ FAPs express Tcf4, and that FAPs
are a dynamic population following injury. Whether Osr1 and Tcf4
mark FAP subpopulations or represent diﬀerent stages of FAP activation
during the course of regeneration remains to be investigated. Interest-
ingly, the fraction of Tcf4+/PDGFRα+ cells decreased between 3 and 7
dpi speciﬁcally in the Osr1+ FAP pool (Fig. S5B). We note that part of
the Tcf4+ cells in the Osr1+ FAP pool appeared to downregulate
PDGFRα over time (Fig. S5B); the identity of Tcf4+/PDGFRαˉ cells
remains to be determined. We further noted expression of Tcf4 in α7-
integrin+ myogenic cells (Fig. S5D) consistent with previous studies
(Mathew et al., 2011).
To corroborate these ﬁndings, FAPs were isolated from Osr1LacZ
animals as linˉ;Sca1+;CD34+ and analyzed via FACS for LacZ and
PDGFRα expression (Fig. S6). Since LacZ staining can generate high
background, we gated conservatively likely leading to exclusion of
positive cells (Fig. S6A, B). Regardless, we could conﬁrm Osr1-LacZ
expression in 3 dpi linˉ;Sca1+ FAPs, and that LacZ+;Sca1+ FAPs
strongly overlapped with PDGFRα expression (Fig. S6C). Adult FAPs
originate from a developmental Osr1+ lineage (Vallecillo-García et al.,
2017). Consistent with these ﬁndings, long-term lineage tracing using
Osr1GCE;R26LacZ animals Tamoxifen pulsed at p0 and p1 shows that the
progeny of Osr1+ developmental cells expand in the injury region upon
acute muscle injury in adult animals (Fig. 2D). Taken together, these
data show that Osr1 expression is induced upon muscle injury speciﬁ-
cally in FAPs within the injured region.
2.3. Osr1 expression identiﬁes injury-activated FAPs that contribute to
adipogenic inﬁltration and post-injury resident FAPs
An initial rapid induction of proliferation is a hallmark of FAP ac-
tivation in response to injury (Joe et al., 2010; Uezumi et al., 2010;
Lemos et al., 2015) which is followed by apoptosis (Lemos et al., 2015).
Following injury, we noted Ki67-stained Osr1+ cells in tissue sections
from Osr1LacZ animals (Fig. 3A). Next, FAPs were isolated (linˉ;α7-in-
tegrinˉ;Sca1+) from Osr1GCE animals before injury and at 3, 5 and 7 dpi.
FAPs showed virtually no proliferative activity in uninjured muscle
(Fig. 3B). In fact, amongst overall 19,.710 non-injury FAPs counted,
only 62 Ki67+ cells (0,31%) were detected. After injury, Osr1+ FAPs
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showed a signiﬁcantly higher fraction of Ki67+ cells than Osr1ˉ FAPs
(Fig. 3B). Nevertheless, Osr1ˉ FAPs, which likely represent FAPs from
the uninjured part of the TA muscle, showed considerable proliferative
activity after injury. This observation may reﬂect an activation of FAPs
to an “alert” state that has been reported in the contralateral muscles of
injured mice including increased in vitro as well in vivo cycling (Rodgers
et al., 2014). Notably, using the Osr1GCE reporter, Osr1+ FAPs in-
creased about twofold in numbers in contralateral muscle (6,9% in
contralateral as compared to 3,3% in uninjured muscle; see Figs. 2B and
S7). Osr1+ contralateral FAPs were 4,3% positive for Ki67 as compared
to 1,6% of Osr1ˉ contralateral FAPs, although the diﬀerence did not
reach statistical signiﬁcance (Fig. S7). Thus, Osr1 expression is acti-
vated upon induction of the alert state, but not all alert FAPs express
Osr1. This together with the observation that ~10% of Osr1ˉ FAPs in
injured muscle express Ki67 suggests that Osr1 does not mark the entire
activated FAPs population at any given time point. Whether this is due
to dynamic changes in gene expression concomitant with FAPs diﬀer-
entiation or whether diﬀerent FAPs subsets exists remains to be in-
vestigated. Since apoptosis is a default fate of the majority of injury-
activated FAPs (Lemos et al., 2015), we tested Osr1+ and Osr1ˉ FAPs by
immunolabeling for cleaved caspase-3 at 3 and 7 dpi representing early
and late time points of recovery. At 3 dpi cleaved caspase-3 could only
be detected in a small proportion of FAPs (70 out of 68,.685 FAPs
counted; approx. 0,1%) with no signiﬁcant diﬀerence between Osr1+
and Osr1ˉ FAPs (Fig. 3C). However, at 7 dpi apoptotic cells were sig-
niﬁcantly increased in the Osr1+ FAPs population (Fig. 3C) consistent
with the proposal that Osr1+ cells are activated in response to injury to
undergo forced cell cycle entry as well as apoptosis.
We next tested the suitability of the Osr1GCE allele (expressing an
inducible CreERt2 recombinase from the Osr1 locus) to trace the fate of
activated FAPs. We genetically labelled Osr1+ cells in Osr1GCE;R26mTmG
mice for ﬁve consecutive days beginning with the day of injury
(Fig. 3D). Since the Osr1+ FAPs population expands in the injured re-
gion during this period, we would anticipate labeling of the activated
FAPs pool as compared to FAPs in uninjured muscle. Consistent with
this prediction, we observed that pulsing Osr1+ cells for ﬁve days be-
fore injury resulted in low levels of labeling as compared to labeling
post injury (Fig. S8). This also suggests that Osr1+ cells in adult un-
injured muscle do not represent a speciﬁc subpopulation prone to quick
expansion upon injury, rather, we propose that sporadic Osr1 expres-
sion in uninjured adult muscle results from activated FAPs engaged in
focal repair, however this requires further investigation. Lineage tra-
cing in Osr1GCE;R26mTmG mice induced after injury was performed at
28 days after injury, where regeneration is almost completed, however
the regenerated tissue can be recognized by centrally located myonu-
clei. The majority of Osr1+ cell progeny after injury was traced to in-
terstitial PDGFRα+ cells representing resident FAPs (Fig. 3D). Osr1+
cells also gave rise to interstitial Tcf4+ cells (Fig. 3D). This suggests that
Fig. 1. Osr1 is sporadically expressed in adult FAPs. (A) X-Gal staining on several Osr1LacZ/+ adult mouse muscles shows sporadic X-Gal+ cells. (B) X-Gal positive
cells also express PDGFRα. (C) Isolation of CD45ˉ;CD31ˉ;Ter119ˉ;α7integrinˉ;Sca1+ FAPs from adult uninjured tibialis anterior of Osr1LacZ mice followed by cytospin
shows that only FAPs express Osr1 (n=3 animals). Data are represented as means +/− s.e.m. (D) Semiquantitative PCR on interstitial populations isolated from
adult PW1LacZ mice. Faint Osr1 expression can be detected in PDGFRα+ PICs.
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Osr1+ activated FAPs return to the resident FAP pool after regeneration
as well as to the Tcf4+ muscle connective tissue ﬁbroblasts consistent
with the proposal that FAPs are a primary source for ﬁbrosis in de-
generative disease (Uezumi et al., 2011; Lemos et al., 2015; Contreras
et al., 2016; Mueller et al., 2016). It is tempting to speculate that Tcf4
might mark FAPs more prone for ﬁbrogenic diﬀerentiation during
muscle regeneration, which is supported by the notion that Tcf4 can
inhibit adipogenesis in vitro (Cawthorn et al., 2007). Whether Osr1 la-
bels cells more likely to diﬀerentiate along the adipogenic lineage will
be an interesting avenue to follow.
In addition to being a source of ﬁbrotic tissue in pathologically re-
modeled skeletal muscle, FAPs are also proposed to be a source of fatty
inﬁltration (Uezumi et al., 2011; Uezumi et al., 2010; Kopinke et al.,
2017; Lemos et al., 2012). Therefore, we tested the adipogenic potential
of Osr1+ injury-activated FAPs by glycerol injury in Osr1GCE;R26mTmG
mice, which results in fatty inﬁltration (Pisani et al., 2010) (Fig. 3E).
14 days after injury, the regenerating region contains inﬁltrating adi-
pocytes which are mG positive (Fig. 3E). Taken together, these results
provide a key conﬁrmation for endogenous FAP ﬁbrotic and adipogenic
fates in situ.
2.4. Osr1 marks a transient population of juvenile Sca1+ cells
We noted previously that Osr1 expression fades in early postnatal
Fig. 2. Osr1 expression is reactivated in FAPs upon acute injury. (A) X-Gal staining on Osr1LacZ/+ adult tibialis anterior muscle 3 and 5 dpi shows accumulation of
Osr1-LacZ positive cells in the injury region. (B) FACS analysis of linˉ;α7-integrinˉ;Sca1+ FAPs isolated before injury or at 3, 5, 7 and 10 dpi from Osr1GCE/+ mice for
Osr1-GFP expression (n=3 animals for each time point). Data are represented as means +/− s.e.m. (C) Quantiﬁcation of cytospin analysis of GFP+ and GFPˉ FAPs
isolated at indicated time points after injury from Osr1GCE/+ mice (n= 3 animals). Data are represented as means +/− s.e.m. (D) Long-term lineage tracing using
Osr1GCE;R26LacZ animals Tamoxifen pulsed at p0 and p1; progeny of perinatal Osr1+ cells stains positive for X-Gal.
J. Stumm et al. Stem Cell Research 32 (2018) 8–16
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life (Vallecillo-García et al., 2017), which is a period of still active
myogenesis. Furthermore, early postnatal development represents a
dynamic phase in which the transition of developmental progenitors to
resident stem cells is accomplished. On this background, we ﬁnally re-
analyzed Osr1 expression in juvenile mice. In young mice (p7) β-Gal
from the Osr1LacZ allele was expressed in muscle interstitial cells
(Fig. 4A), most of which were PDGFRα+ (86,1%; Fig. 4B). This in-
dicates that Osr1 is predominantly expressed in juvenile interstitial
PDGFRα+ cells that likely are FAPs / FAP progenitors and hence should
also express Sca1 (Uezumi et al., 2010; Pannerec et al., 2013).
Juvenile Sca1+ cells had been analyzed on the background of
muscle interstitial PICs (Pannerec et al., 2013). This study showed that
juvenile Sca1+ cells can be subdivided into two populations: one with
low/medium Sca1 expression levels (Sca1med) and a population with
high Sca1 expression (Sca1hi) that persists throughout life and com-
pletely overlaps with FAPs. We therefore FACS-isolated Sca1med;PW1+
and Sca1hi;PW1+ PICs from 7 day old PW1LacZ mice as previously de-
scribed (Pannerec et al., 2013) and analyzed Osr1 expression by semi-
quantitative PCR. Strong Osr1 expression was seen in Sca1med, whereas
lower levels of expression were detected in Sca1hi PICs. No detectable
levels of expression were found in Sca1hiPW1ˉ cells or in satellite cells
(Fig. 4C).
To further characterize Osr1+ juvenile cells, we ﬁrst FACS isolated
linˉ;CD34+;Sca1med and linˉ;CD34+;Sca1hi cells from Osr1LacZ mice
(Fig. 4D). The majority of Sca1med cells were β-Gal positive (79%), of
which almost all Sca1med;β-Gal+ cells were PDGFRα positive (95%;
Fig. 4E). In contrast, Sca1med;PDGFRα+ cells were mostly β-Gal posi-
tive (94%; Fig. 4F). The Sca1hi population contained distinct and se-
parable β-Gal+ and β-Galˉ subpopulations. Interestingly, of the
Sca1hi;β-Gal+ population only approx. 50% expressed PDGFRα
(Fig. 4G). In contrast, most of the Sca1hi;PDGFRα+ cells were β-Gal+
(78%; Fig. 4H), showing a prevalence for Osr1 expression in the
Fig. 3. Osr1 marks injury-activated ﬁbro-adipogenic progenitors (FAPs). (A) X-Gal+ (Osr1 expressing) cells in the injury region (Osr1LacZ/+ animal; 3dpi) are positive
for the cell cycle marker Ki67. (B, C) Cytospin of linˉ;α7-integrinˉ;Sca1+ FAPs FACS-isolated at indicated days post injury (dpi) and separated into GFP+ and GFP−
populations were stained for the proliferation marker Ki67 (B) and the apoptosis marker cleaved caspase-3 (C). Quantiﬁcation shown right (n= 3 independent
experiments from 3 animals). (D) Lineage tracing of Osr1+ cells in Osr1GCE;R26mTmG animals Tamoxifen-pulsed for ﬁve consecutive days after freeze-pierce injury.
Contribution of Osr1+ cells to PDGFRα+ and Tcf4+ interstitial cells was analyzed 28 days post injury (dpi). Quantiﬁcation is shown below (n=3 independent
experiments from 3 animals). (E) Lineage tracing of Osr1+ cells in Osr1GCE;R26mTmG animals Tamoxifen-pulsed for ﬁve consecutive days after glycerol injection
injury. Contribution of Osr1+ cells to ectopic adipose tissue labelled for Perilipin (PLIN) was analyzed at 14 dpi. Data are represented as means +/− s.e.m. t-test:
*= P < 0,05, **= p < 0,01, ***= p < 0,005, n.s. = not signiﬁcant.
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Fig. 4. In juvenile mice Osr1 is expressed in a transient Sca1med population. (A) X-Gal staining on 7 day old Osr1LacZ/+ tibialis anterior muscle shows Osr1-LacZ+
interstitial cells. (B) Osr1-LacZ+ cells are mostly positive for PDGFRα in situ (n= 3 animals). (C) Semiquantitative PCR on interstitial populations isolated from 7 day
old PW1LacZ mice. Strong Osr1 expression can be detected in Sca1med PICs, while faint Osr1 expression can be detected in Sca1hi PICs. (D) Isolation of CD34+/Sca1+
cells from 7 day old tibialis anterior muscles; the Sca1med and Sca1hi populations are discernible. (E, F) Analysis of the Sca1med population. (E) Sca1med cells are
mostly PDGFRα+; Sca1med PDGFRα+ cells mostly express β-Gal. (F) Sca1med; β-Gal+ cells express PDGFRα. (G, H) Analysis of Sca1hi cells. (G) Sca1hi cells are only in
part positive for PDGFRα; Sca1hi;PDGFRα+ cells mostly express β-Gal. (H) Only approx. Half of Sca1hi cells express β-Gal; Sca1hi; β-Gal+ cells are also only in part
PDGFRα+. (I-L) Lineage analysis of perinatal Osr1+ cells. (I) Lineage tracing strategy. Tamoxifen was administered at p0/p1, analysis was performed at 3 weeks of
age; adipogenic diﬀerentiation was analyzed at 7 weeks of age. (J) Osr1+ progeny majorly express PDGFRα, but in part also Tcf4. Quantiﬁcation shown right (n=2
animals). (K) Osr1+ cells do not give rise to CD31+ endothelial cells or αSMA+ smooth muscle cells. (L) Osr1+ cells give rise to muscle interstitial adipocytes
labelled for Perilipin (PLIN). Data are represented as means +/− s.e.m.
J. Stumm et al. Stem Cell Research 32 (2018) 8–16
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PDGFRα fraction. Taken together, these results show that Osr1 is ex-
pressed primarily in interstitial Sca1med;PDGFRα+ cells and to lower
extent in Sca1hi;PDGFRα+ cells in juvenile muscle.
We next re-analyzed the developmental fate of perinatal Osr1+ cells
by genetically labeling the Osr1 lineage in Osr1GCE;R26mTmG mice.
Administration of Tamoxifen (TAM) at p0 and p1 was used to devel-
opmentally trace Osr1+ cells (Fig. 4I). At day p21, Osr1+ progenitors
contributed to the muscle interstitial PDGFRα cell pool (approx. 70%;
Fig. 4J) in line with our previous demonstration that adult FAPs derive
from these developmental Osr1+ cells (Vallecillo-García et al., 2017).
Osr1 descendants were also present in cells expressing the muscle
connective tissue ﬁbroblast marker, Tcf4, although at a markedly lower
number (Fig. 4J). No contribution of Osr1+ progenitors was seen in
αSMA+ vascular smooth muscle or CD31+ endothelium (Fig. 4K). In
addition, Osr1+ progenitors gave rise to muscle interstitial adipocytes
(Fig. 4L). This shows that juvenile Osr1+ cells maintain plasticity and
that interstitial ﬁbroblasts as well as interstitial adipocytes derive from
this pool in addition to FAPs.
During embryonic development, Osr1 is expressed in Sca1ˉ cells
whereas Sca1-expressing muscle interstitial cells arise during late fetal
development, concomitant with the appearance of Sca1+/Osr1+ cells
(Vallecillo-García et al., 2017). While it remains unresolved whether
Osr1+ cells acquire Sca1 expression during fetal development or whe-
ther the Sca1+ cells arise de novo, our observation that Osr1 is pre-
dominantly expressed in a transient population of Sca1med FAPs during
postnatal development has interesting implications. Speciﬁcally, we
note that Osr1 is expressed in muscle interstitial mesenchymal cells
throughout embryonic and postnatal myogenesis, ﬁrst in Sca1ˉ, later in
Sca1med and to a lesser degree in Sca1hi cells. This pattern of expression
suggests a lineage continuum in which Sca1hi cells are derived from
Sca1med cells, and that downregulation of Osr1 expression is required
for this diﬀerentiation step. Interestingly, both the disappearance of
Sca1med cells and the downregulation of Osr1 expression correlate with
the termination of postnatal muscle growth driven by incorporation of
new nuclei into myoﬁbers (Pannerec et al., 2013; White et al., 2010).
These data together with the observation of re-activation of Osr1 ex-
pression in injury-activated FAPs leads to the proposal that Osr1 ex-
pression marks FAPs or their progenitors during periods of active
myogenesis. During embryonic myogenesis, Osr1+ cells provide a pro-
myogenic niche for myogenic progenitors that promotes myogenic cell
proliferation and survival. (Vallecillo-García et al., 2017). Similarly,
adult FAPs promote myogenesis in vitro (Joe et al., 2010) and Tcf4+
cells, which in part overlap with FAPs, are required for eﬃcient muscle
regeneration (Murphy et al., 2011). The re-activation of Osr1 expres-
sion further suggests that adult FAPs reactivate a developmental pro-
gram to support tissue regeneration.
In summary, we show that Osr1 is the ﬁrst speciﬁc marker identiﬁed
for injury activated FAPs. Given the key role for FAPs in promoting
proper muscle regeneration, the ability to lineage track these cells will
be valuable for designing approaches to optimize muscle repair and
target the muscle stem cell niche.
3. Materials and methods
3.1. Mice
Mice were maintained in an enclosed, pathogen-free facility. The
targeting construct for the Osr1 multifunctional allele was electro-
porated into G4 mouse ES cells (George et al., 2007). The transgenic
locus was conﬁrmed by Southern blotting and Sanger sequencing.
Successfully recombined clones were subjected to tetraploid aggrega-
tion. Mice were crossed back to wild type C57BL/6j mice for at least 6
generations before establishing the line. The following mouse lines
were described before: Osr1GCE (Mugford et al., 2008); R26LacZ
(Soriano, 1999); R26mTmG (Muzumdar et al., 2007). Mouse experiments
were performed in accordance with European Union regulations
(Directive 2010/63/EU) and under permission from the Landesamt für
Gesundheit und Soziales (LaGeSo) Berlin, Germany (Permission num-
bers ZH120, G0240/11, G0114/14, G0209/15, G0268/16).
3.2. Cell lineage tracing
Lineage tracing of neonatal Osr1+ cells was performed in Osr1GCE/
+;R26lacZ/+ neonates by subcutaneous injection of Tamoxifen (Sigma
Aldrich; solved in 90% (v/v) sunﬂower oil/ 10% (v/v) ethanol) into the
neck fold (75 μg/ g body weight). Lineage tracing of injury-activated
Osr1+ FAPs was performed in Osr1GCE/+;R26mTmG/+ or
Osr1GCE;R26lacZ mice by intraperitoneal injection of Tamoxifen at the
day of injury and the next 4 following days (3mg per injection time
point). For lineage tracing of Osr1+ cells before injury, Osr1GCE/
+;R26RLacZ/+ and Osr1GCE/+;R26RmTmG/+ animals were injected with
3mg Tamoxifen for 5 consecutive days one week before injury.
3.3. Muscle injury
Injury was applied to the tibialis anterior muscle of 3–5months old
Osr1GCE, Osr1lacZ, Osr1GCE;R26mTmG or Osr1GCE;R26lacZ mice using the
freeze-pierce technique. Mice were anesthetized by intraperitoneal in-
jection of 10% (v/v) ketamine / 2% (v/v) xylazine (Rompun® 2%) in
sterile PBS (5 μl / g body weight). Mice were kept on a heating plate
warmed to 37 °C throughout the procedure. The skin above the Tibialis
anterior muscle was opened and the muscle was longitudinally pierced
5 times using a 0.7mm liquid nitrogen cooled syringe needle.
For glycerol injury mice were anesthetized as described above. Skin
above the Tibialis anterior muscle was opened and 25 μl of 50% v/v
glycerol/sterile PBS were injected into the muscle.
3.4. Histology, antibody labeling, western blot
Muscle was dissected, immediately embedded in 6% (w/v) gum
tragacanth (Sigma Aldrich) dissolved in H2O and snap frozen in liquid
nitrogen cooled isopentane (−160 °C). Frozen tissue was sectioned at
7 μm and ﬁxed using 4% (w/v) PFA in PBS for 5min at RT.
Permeabilization of sections was performed in 0.3% (v/v) Triton X-
100 (Sigma Aldrich) in phosphate buﬀer (PBS) for 10min. Sections
from adult tissues were blocked with 5% (w/v) bovine serum albumin
(Sigma Aldrich) in PBS. Sections then preincubated with 5% horse
serum, 5mgmL−1 blocking reagent (Perkin Elmer) and 0.1% Triton X-
100 in PBS for 1 h at RT. Primary antibodies were applied in the same
solution and incubated at 4 °C overnight, followed by secondary anti-
body staining for 1 h at room temperature. Counterstaining was per-
formed with 5 μg μL−1 4′,6-diamidino-2-phenylindole (DAPI;
Invitrogen), slides were mounted with FluoromountG
(SouthernBiotech). Antibodies are listed in Supplementary tables 1 and
2.
For beta galactosidase detection, sections or cells were ﬁxed as
above and incubated at 37 °C overnight in X-Gal (0.16% (w/v) X-Gal,
5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 2 mM MgCl2 in PBS). Beta ga-
lactosidase development was stopped by washing in PBS. For whole-
mount X-Gal stainings embryos were ﬁxed in X-Gal ﬁxing solution (1%
(w/v) Formaldehyde, 0.2% (w/v) Glutaraldehyde, 0.02% (v/v) NP-40,
1% (v/v) PBS in bidest H2O) for 1 h at 4 °C, then stained for 24 h at
37 °C in X-Gal staining solution.
Protein extraction and western blot were performed according to
standard procedures. In brief, muscle tissue was homogenized, RIPA
buﬀer (150mM sodium chloride; 1.0% NP-40 or Triton X-100; 0.5%
sodium deoxycholate; 0.1% SDS (sodium dodecyl sulfate); 50mM Tris,
pH 8.0) was added (0,4 ml per 0,1 g of tissue), and incubated on ice for
15min. After brief centrifugation supernatant was mixed 5:1 with
loading buﬀer (2,4 g SDS; 12mg bromophenol blue; 9,4ml glycerol;
2,4 ml Tris 6.8 (0.5M); 1,8 ml beta-mercaptoethanol; 4,2 ml dd H2O)
and heated at 98 °C for 10min. An aliquot of the supernatant was used
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for determination of protein concentration (Pierce / Thermo Scientiﬁc
BSA Protein Assay Kit). 50 μg of Protein was loaded per lane on an 8%
SDS polyacrylamid gel. Gels were blotted to Amersham Hybond P 0.45
PVDF blotting membrane (activated in methanol for 1min before use).
Membranes were blocked with 5% milk powder (Roth) in TBST, anti-
body incubation (antibodies see supplementary table 1) was performed
in blocking solution at 4 °C over night. Membranes were washed three
times with TBST, antibody detection was performed with the ECL Kit
(Pierce / Thermo Scientiﬁc) according to the manufacturer's instruc-
tions. Imaging and quantiﬁcation were performed on a Fusion FX7
(Vilber Lourmat).
Antibodies used for attempting Osr1 immunolabeling on fresh
frozen sections of injured muscle: Sigma-Aldrich #HPA015525,
#WH0130497M4; Abnova # H00130497-M04; Santa Cruz #sc-
376,545; Abcam #ab74003.
3.5. Cell isolation and ﬂow cytometry
Cell isolation and labeling was essentially performed as described in
(Vallecillo-García et al., 2017). Isolation of cells from Osr1GCE/+ mice
was performed as follows: Brieﬂy, whole hind limb or tibialis anterior
muscles were carefully isolated, roughly minced and digested in high-
glucose DMEM medium containing 10% fetal calf serum (FCS, Bio-
chrom), 1% Penicillin Streptomycin solution (P/S; 10,000 U/ml) and
2,5 mg/ml Collagenase A (Roche) for 75min at 37 °C with vigorous
shaking. 2 IU/ml of Dispase II (Sigma Aldrich) were added to the di-
gestion solution and muscle lysates were digested for further 30min.
Muscle slurries were passed 10 times through a 20G syringe (BD
Bioscience) and a 70-μm cell strainer. Cells were collected by cen-
trifugation at 300 g for 5min and resuspended in staining buﬀer con-
sisting of 500 μl Hank's balanced salt solution (HBSS, Thermo Fisher
scientiﬁc), 0.4% bovine serum albumin (Sigma Aldrich) and 20 μg/ml
Gentamycin (Serva Electrophoresis). Cells were stained on ice for
30min and washed twice with staining buﬀer previous to FACS sorting.
Propidium iodide was used as a viability dye. Isolation of cells from
Osr1LacZ/+ animals was performed as follows: freshly dissected muscle
tissue was minced and digested in HBSS (Gibco) supplemented with
2.4 U/ml Dispase II (Roche), 2 μg/ml Collagenase A (Roche), 0.4mM
CaCl2, 5 mM MgCl2, 10 ng/ml DNase I (Roche) for 2 h at 37 °C under
agitation. Single cell suspension was obtained after 3 successive cycles
of straining and washing in Washing Buﬀer consisting of HBSS con-
taining 0.2% (w/v) BSA (Sigma Aldrich), 1% (v/v) penicillin-strepto-
mycin, 10 ng/ ml DNAse I and 10% (v/v) mouse serum. Cells were
incubated with primary antibodies for 1 h on ice. The suspension was
subjected to 2 washing steps, resuspended in Washing Buﬀer and to
LacZ reporter staining using C12FDG (Life Technologies). For lacZ
staining C12FDG was added to the cell suspension to a ﬁnal con-
centration of 600 μM and incubated for 30min at 37 °C. 2 washing steps
followed before proceeding to FACS analysis. Cells puriﬁed by sorting
were cytospun to coverslips. Coverslips were coated with poly-L-lysine
by incubation with a 10-fold solution of poly-lysine in bidest H2O for
1 h at RT, rinsed twice in bidest H2O and air dried. Puriﬁed cells were
added to prepared slides and allowed to adhere for 1 h at 4 °C. Super-
natant was removed by centrifugation at 50 rcf for 5min at 4 °C, cells
were ﬁxed using 4% (w/v) PFA in PBS for 5min at RT and permeabi-
lized with 0.3% (v/v) Triton X-100 in PBS for 5min at RT. Antibodies
are listed in Additional ﬁle 1, Supplementary tables 1 and 2. Sorts and
analyses were performed on a FACS Aria II (BD Biosciences). Sorting
gates were deﬁned based on unstained controls. Data were collected
using FACSDIVA software. Biexponential analyses were performed
using FlowJo 10 (FlowJo LLC) software. Analysis was performed on
three independent biological replicates.
3.6. Cell quantiﬁcation
Quantiﬁcation of FACS-isolated Osr1+ cells after immunolabeling
(cytospin) was performed on at least three independent biological re-
plicates (i.e. cells FACS isolated from three diﬀerent animals).
Quantiﬁcations of cytospun cells for X-Gal staining and PDGFRα, Tcf4
were made from two areas of 0.81mm2 per replicate. Quantiﬁcation of
Ki67+ and cleaved caspase 3+ cells was performed on a tile scan image
comprising the whole cover slip. The image analysis module of the
Leica Las X software was used for cell counting. Student's t-test was
performed using Prism 5 (GraphPad) software. Error bars in all ﬁgures,
including supplementary information, represent the mean ± standard
error of the mean (s.e.m).
3.7. Microscopy
Images were acquired using a Zeiss LSM700 confocal microscope, a
Leica DMR or Leica DMi8 microscope. Bright ﬁeld images of whole-
mount embryos were taken with a Leica Leica MZ12 stereo microscope.
Images were captured using Axio Vision Rel. 4.8 and Zen 2010 (Zeiss)
or LAS X (Leica).
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